Biblio

Found 17 results
Filters: Keyword is Disease Progression  [Clear All Filters]
2013
H. Yun Park, Churg, A., Wright, J. L., Li, Y., Tam, S., Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., and Sin, D. D., Club cell protein 16 and disease progression in chronic obstructive pulmonary disease., Am J Respir Crit Care Med, vol. 188, no. 12, pp. 1413-9, 2013.
H. O. Coxson, Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. Ma, Celli, B., Crim, C., Duvoix, A., Fauerbach, P. Nasute, Lomas, D. A., MacNee, W., Mayer, R. J., Miller, B. E., Müller, N. L., Rennard, S. I., Silverman, E. K., Tal-Singer, R., Wouters, E. Fm, and Vestbo, J., The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study., Lancet Respir Med, vol. 1, no. 2, pp. 129-36, 2013.
C. J. Ryerson, Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., and Collard, H. R., Prevalence and prognosis of unclassifiable interstitial lung disease., Eur Respir J, vol. 42, no. 3, pp. 750-7, 2013.
H. Yun Park, Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., Anthonisen, N. A., and Sin, D. D., The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD)., PLoS One, vol. 8, no. 4, p. e61315, 2013.
A. Hakimi Shoki, Mayer-Hamblett, N., Wilcox, P. G., Sin, D. D., and Quon, B. S., Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations., Chest, vol. 144, no. 5, pp. 1659-70, 2013.
J. A. Russell, Fjell, C., Hsu, J. L., Lee, T., Boyd, J., Thair, S., Singer, J., Patterson, A. J., and Walley, K. R., Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock., Am J Respir Crit Care Med, vol. 188, no. 3, pp. 356-64, 2013.